Status:
COMPLETED
Understanding and Overcoming the Racial/Ethnic Inequalities in COVID-19 Vaccination Acceptance
Lead Sponsor:
University of Essex
Collaborating Sponsors:
University of Southern California
Department of Health and Social Care
Conditions:
Vaccine Refusal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
With the constant threat of new epidemic waves and the emergence of variants, COVID-19 resilience can only be attained when a sufficient level of immunity is achieved. Yet, in the US and the UK, COVID...
Eligibility Criteria
Inclusion
Exclusion
- if participants complete the study in less than 5 minutes
- if participants complete the study without paying attention (as indicated by their answers to two attention check questions)
Key Trial Info
Start Date :
February 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 5 2022
Estimated Enrollment :
4039 Patients enrolled
Trial Details
Trial ID
NCT05238428
Start Date
February 3 2022
End Date
March 5 2022
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qualtrics. The data is gathered via an online platform.
London, United Kingdom